Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors

Recombinant Newcastle disease virus expressing human interleukin-2 serves as a potential candidate for tumor therapy

Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial

An effective tumor vaccine optimized for costimulation via bispecific and trispecific fusion proteins

Brain tumor therapy by combined vaccination and antisense oligonucleotide delivery with nanoparticles

Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses

Second International Conference on Cancer Vaccines/Adjuvants/Delivery for the Next Decade (CVADD): Heidelberg, Germany, 10-12 October 2007

Generation of a recombinant oncolytic Newcastle disease virus and expression of a full IgG antibody from two transgenes

Host mediated anti-tumor effect of oncolytic Newcastle disease virus after locoregional application

Recombinant Newcastle disease virus (NDV) with inserted gene coding for GM-CSF as a new vector for cancer immunogene therapy